Blocking TNF production could offer a more effective solution for the treatment of COVID-19.
The number of reported global daily deaths from the coronavirus reached 10,816 on Nov. 17, according to a Reuters tally, the highest single-day death count as the virus’ global epicenter the United States entered winter.
Antibodies against the novel coronavirus declined rapidly in the British population during the summer, a study found, suggesting protection after infection may not be long lasting and raising the prospect of waning immunity in the community.
The United States, Russia and France set new daily records for coronavirus infections as a second wave swelled across parts of the Northern Hemisphere, forcing some countries to impose new curbs.
The number of new Covid-19 cases in the United States last week rose 13% to more than 393,000, approaching levels last seen during the summer peak, according to a Reuters analysis.
The United States surpassed 170,000 coronavirus deaths, according to a Reuters tally, as health officials express concerns over Covid-19 complicating the fall flu season.
Healthcare providers – including CVS Health Corp. – are kicking off flu vaccinations early, ordering extra shots and aiming to add tests that check for both the annual flu and COVID-19, pharmacy executives and experts told Reuters.
Full-service health and wellness marketing agency Fingerpaint added 23 paid college interns to their employee roster on June 8, and they are operating the entire program through a virtual experience.
First indications of the effectiveness of a potential vaccine against coronavirus may be available in the autumn, the head of the GAVI vaccine alliance told a Swiss newspaper, forecasting a long road from there to broad availability.
Americans were back on the road after more than two months of coronavirus lockdowns that kept them homebound, with beach-area traffic tripling since the low point in mid-April.
